BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.
Last month in BMC Cancer
Support and Guidance
Planning to submit a systematic review?
Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here.
Submitting a study protocol?
Find out more about the journal's criteria and scope for study protocols here.
Are cancer patients better off if they participate in clinical trials?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Articles
-
-
Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial
-
Limited recurrence distance of glioblastoma under modern radiotherapy era
-
Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
-
Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
-
Atypical glandular cells in conventional cervical smears: Incidence and follow-up
Featured video: Microparticles, breast cancer's secret weapon?
Your browser needs to have JavaScript enabled to view this video
Welcome
Call for submissions: 'Targeted Therapy' Collection
The Editors of BMC Cancer and BMC Medicine invite of submissions to our ‘Targeted Therapy’ cross journal collection. Guest edited by Prof. Min Li (University of Oklahoma Health Sciences Center, USA) and Dr. Yanis Boumber (The Northwestern University, USA).
We advise to submit by 1st August 2021 if you would like your manuscript to be ready for the launch date.
Call for Submissions: 'Microbiome and Cancer' Collection
The Editors of BMC Cancer, BMC Microbiology and Microbiome invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin.
Open for submissions until 30th September 2021.
BMC Series Focus Issues
© borgogniels
June: Water and Sanitation.
In celebration of World Environment Day on the 5th June, the BMC Series presents a focus issue on Water and Sanitation. We have collated open-access content from across our journals to highlight research into clean water, investigating links between water and health and our overall relationship with water.
(c) sankai - Getty Images - iStock
May: Understanding Mental Health
With Mental Health Awareness Month in May, the BMC Series presents a focus issue on ‘Understanding Mental Health’. We have brought together content to highlight research into understanding and improving mental health.
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last 6 months!
BMC Series Blog
Editorial: Nobel Prize Cancer Immunotherapy!
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
Follow
Annual Journal Metrics
-
Speed
79 days to first decision for reviewed manuscripts only
55 days to first decision for all manuscripts
170 days from submission to acceptance
16 days from acceptance to publicationCitation Impact
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)Usage
5,089,371 Downloads
2,117 Altmetric Mentions